We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo Settles Patent Suit Over Paxil

Law360 (January 2, 2004, 12:00 AM EST) -- GlaxoSmithKline settled a lawsuit against Synthon Pharmaceuticals, clearing the way for generic drug maker to immediately start selling Pexeva, its competitor to the U.K. pharmaceutical giant’s antidepressant Paxil.

A separate case pending before the U.S. Patent and Trademark Office will determine whether Synthon must pay GSK royalties on Pexeva sales.

Glaxo had sued Synthon for patent infringement in the U.S. District Court for the North Carolina Middle District on Nov. 22, 2000, and the two-week trial had been scheduled for Jan. 12.

Paxil is one of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.